about
Cancer Risk in Patients With Empyema: A Nationwide Population-Based StudyThe essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesisAssociations between prediagnostic blood glucose levels, diabetes, and glioma.Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.Risk factors for cancer development in type 2 diabetes: A retrospective case-control studyImpact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.Biological Mechanisms for the Effect of Obesity on Cancer Risk: Experimental Evidence.Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic StudyAssociation between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categoriesMethylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis.ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose.Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathwayHyperglycemia triggers HIPK2 protein degradation.Resveratrol in the treatment of pancreatic cancer.Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk.Modulation of Mammary Stromal Cell Lactate Dynamics by Ambient Glucose and Epithelial Factors.Hypoxia driven glycation: Mechanisms and therapeutic opportunities.Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal CancerGestational diabetes mellitus may be associated with increased risk of breast cancer.Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study.Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathwayAnthocyanins from Purple Corn Ameliorated Tumor Necrosis Factor-α-Induced Inflammation and Insulin Resistance in 3T3-L1 Adipocytes via Activation of Insulin Signaling and Enhanced GLUT4 Translocation.Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment.Thymic emigration patterns in patients with type 2 diabetes treated with metformin.Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature.Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan.Prognostic Significance of Hyperglycemia in Patients with Brain Tumors: a Meta-Analysis.Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors.High glucose contributes to the proliferation and migration of non-small cell lung cancer cells via GAS5-TRIB3 axis.Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner.Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.High glucose induces epithelial-mesenchymal transition and results in the migration and invasion of colorectal cancer cells.Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation.Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9)Inhibitory Effect of Extract on Hyperglycemia-Related Expression and Cancer Proliferation
P2860
Q27315538-C85B6694-EF08-4F02-95DE-8D2AD7921BDAQ33654365-3F670DE7-C95A-4251-B4E6-EC89471EDB78Q33684013-AB8003BE-2456-4120-937E-E1342C98BF85Q33756429-20C5D126-D412-4E8C-ACA0-CDBB331BF2FCQ36159846-C9962C98-FDFC-454D-8DD5-DA90A90F6534Q36194195-6A544DB7-A34F-4AFA-985F-3BB2BDD20C4FQ36210928-93914544-6E46-411B-AC46-153FA7FA8106Q36712191-6242CF1A-4D11-4869-8395-DD4443C28942Q37045608-627FF875-3B4B-43CA-85FA-0A9E7E918DA9Q37368367-076DC14D-2C2E-49E7-9D4F-D6D591960EDCQ37412531-DE6FD6D3-D57F-4C6C-9CE9-B557C6AC7407Q37437564-213E8CEC-7BFC-45AF-A52E-E235541645FDQ37702069-51CEC368-FC63-4C69-8A79-D7F66F88BF96Q38568979-30839C29-38E5-4CD2-A843-5D3E534DA3A8Q38765310-AAFDC60B-6F9E-458F-82EC-1211DA468999Q38781401-69E186A2-9C64-40EC-9189-E86A9C3A9479Q39331191-5C6CDF24-1A2D-437F-815A-BE9AD0CCDC10Q39519100-A1211082-48A7-4C73-9DCD-39334BF6751EQ40332297-92494E40-600B-44CC-BF6B-5A5512F0B1BDQ41248320-3681AA7B-FB06-4E4A-AACE-714CBA08FF09Q41888320-8D7AF1CE-A66A-4C06-B702-F65860139399Q42339288-AA34BD01-A85D-46D7-8411-A2F792DD1769Q42513060-AC78BD24-8B9E-4B8A-8B04-EDD70B346D6EQ47390152-99A0CD9D-1B73-4647-A45B-B3E1D0864E6CQ47826565-B9A94DF0-2B3B-40EE-B35F-06D911C69DA3Q47879050-79753AA1-E8DE-49FA-9AAD-E2C3A2DAA661Q48159837-798B50AE-4AF2-4AA3-BFDB-0C676DB98D00Q48325616-4C24E3C0-9321-470D-8E6F-E36D1A66C4D4Q49627304-CD4109D1-05F8-4358-99A5-E8F842247F33Q49788560-C1980F85-BBE6-4105-AAC3-E5970072ABA4Q50934772-D509A108-FC16-4690-BF1B-C6C30942CF09Q51734662-5DF71031-B62B-440A-96BB-CA62B950AC78Q55281546-C44F5AF3-5B73-42D2-AEFD-6B404BAD8226Q55347754-01A25C95-D220-43D3-8955-374F1E03D00FQ58553684-0CF558D6-4B43-4A74-AC40-C15E8ECA388BQ58803433-C2E05A39-1E6F-4694-AB42-973741BD410F
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hyperglycemia as a risk factor for cancer progression
@ast
Hyperglycemia as a risk factor for cancer progression
@en
Hyperglycemia as a risk factor for cancer progression.
@nl
type
label
Hyperglycemia as a risk factor for cancer progression
@ast
Hyperglycemia as a risk factor for cancer progression
@en
Hyperglycemia as a risk factor for cancer progression.
@nl
prefLabel
Hyperglycemia as a risk factor for cancer progression
@ast
Hyperglycemia as a risk factor for cancer progression
@en
Hyperglycemia as a risk factor for cancer progression.
@nl
P2093
P2860
P3181
P1476
Hyperglycemia as a risk factor for cancer progression
@en
P2093
Jiyoung Park
Philipp E. Scherer
Tae Young Ryu
P2860
P3181
P356
10.4093/DMJ.2014.38.5.330
P577
2014-10-01T00:00:00Z